Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 208757
Company: ACTAVIS LABS UT INC
Company: ACTAVIS LABS UT INC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BENZOYL PEROXIDE AND CLINDAMYCIN PHOSPHATE | BENZOYL PEROXIDE;CLINDAMYCIN PHOSPHATE | 3.75%; EQ 1.2% BASE | GEL;TOPICAL | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/12/2021 | ORIG-1 | Tentative Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/208757Orig1s000TA_ltr.pdf |